Reinhard Wallich Selected Research

OspC protein

1/2015	Soluble cysteine-rich tick saliva proteins Salp15 and Iric-1 from E. coli.
1/2015	Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
6/2006	Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhard Wallich Research Topics

Disease

20	Lyme Disease (Disease, Lyme) 06/2015 - 03/2003
13	Infections 06/2015 - 03/2003
4	Relapsing Fever 01/2017 - 06/2007
3	Neoplasms (Cancer) 06/2010 - 11/2004
1	Bacterial Meningitis 01/2016
1	Staphylococcal Infections 01/2016
1	Tick Bites 01/2015
1	Hepatitis 08/2012
1	Necrosis 01/2012
1	Pathologic Processes 05/2010
1	Virus Diseases (Viral Diseases) 11/2004
1	Joint Diseases (Joint Disease) 01/2004

Drug/Important Bio-Agent (IBA)

19	Complement System Proteins (Complement)IBA 01/2017 - 04/2004
10	Membrane Proteins (Integral Membrane Proteins)IBA 06/2015 - 04/2005
8	Proteins (Proteins, Gene)FDA Link 10/2010 - 02/2005
4	1-oleoyl-2-stearoylphosphatidylcholineIBA 01/2015 - 01/2005
4	Complement Factor H (Factor H)IBA 10/2010 - 06/2007
4	AntigensIBA 03/2008 - 03/2003
4	VaccinesIBA 01/2008 - 03/2003
4	AntibodiesIBA 01/2008 - 03/2003
3	OspC proteinIBA 01/2015 - 06/2006
3	PerforinIBA 08/2012 - 11/2004
3	Granzymes (Granzyme)IBA 08/2012 - 11/2004
2	PlasminogenIBA 01/2009 - 06/2007
2	Borrelia burgdorferi complement regulator-acquiring surface proteinsIBA 09/2008 - 09/2007
2	Immunoglobulin IsotypesIBA 01/2008 - 02/2005
2	EpitopesIBA 01/2008 - 02/2005
2	Lipoproteins (Lipoprotein)IBA 06/2006 - 01/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2005 - 11/2004
1	Fibronectins (Fibronectin)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Cysteine (L-Cysteine)FDA Link 01/2015
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2014
1	LectinsIBA 01/2013
1	Antiviral Agents (Antivirals)IBA 08/2012
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2012
1	CollagenIBA 01/2012
1	Hyaluronic Acid (Hyaluronan)IBA 01/2012
1	LigandsIBA 10/2010
1	Fibrinolysin FDA Link 01/2009
1	Messenger RNA (mRNA)IBA 09/2007
1	Virulence Factors (Pathogenicity Factors)IBA 06/2007
1	Lipoprotein(a)IBA 01/2006
1	DefensinsIBA 10/2005
1	Nitrogen OxidesIBA 10/2005
1	EnzymesIBA 10/2005
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2005
1	OspA proteinIBA 02/2005
1	AcidsIBA 02/2005
1	PhosphatidylserinesIBA 11/2004
1	Caspase InhibitorsIBA 11/2004
1	Caspase 3 (Caspase-3)IBA 11/2004
1	Oxygen (Dioxygen)IBA 11/2004
1	Interferon-gamma (Interferon, gamma)IBA 11/2004
1	Toll-Like Receptor 2IBA 01/2004
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2004
1	LipopolysaccharidesIBA 01/2004